P0CT10 Sterol 24-C-methyltransferase MolNFT, Molecular NFT on GenesisL1

Sterol 24-C-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiboa3o47dyidjvt4odqvhjfmlcs7sk7odcb4o3hqisjvipmyfijnu/metadata.json

IPFS of structure file:

bafybeie27qtfzbjcn3hgtkq2rhcptgcrfmxj3fk3e7ry5yhy4hrkzgktrq/AF-P0CT10-F1-model_v2.pdb

First NFT owner address (eip-55):

0x8BD7f91495A0EDa7B1D4f7CeF7b51C4d1bb1aA84

First NFT owner address (bech32):

genesis130tlj9y45rk60vw57l800dguf5dmr25yctkfcv

Current NFT ID #119817 owner (web3):

0xeD1A6159e26791F22a6cE039130D208Ac313c418

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
119817
Accession (UniProt):
P0CT10
Name::
Sterol 24-C-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
MAGNAPORTHE ORYZAE (STRAIN 70-15 / ATCC MYA-4617 / FGSC 8958)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P0CT10 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P0CT10|ERG6_MAGO7 Sterol 24-C-methyltransferase OS=Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) OX=242507 GN=ERG6 PE=3 SV=1 MSKQQHPSSKTQITRRRDTADMTFEQVLHKGSSANMGGLSSMLGKDREASKTAVDQYFRHWDGKTAKTETTKVREERKADYATLTRQYYNLVTDFYEYGWGQSFHFCTFAPGETFASAITRYEHTLAHRIGIKKGMKVLDIGCGVGGPARQIAKFTGANITGITINEYQVERARRYAEMEGYGAGEQLKFVQGDFMALPFEKETFDAVYSIEATVHAPKLEDVYKQIFNVLKPGGIFGLYEWVMTDAYDENDPHHKEIRFGIEHGGGIANLQTAQTAIAAIKAAGFELLESEDLADNSDRAPWYWPLGGNAWQYASTFGDILSTFTMTPAGRAIAHTVLGVVESIGLVPPGTKKTADSLSTTAAALVAGGKEGLFTPMFLMVARKPVAKE

P0CT10 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P0CT10 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience